Company Filing History:
Years Active: 2019-2024
Title: The Innovations of John Malcolm Tabor
Introduction
John Malcolm Tabor is a notable inventor based in Syracuse, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. With a total of 5 patents, Tabor's work has had a substantial impact on medical research and therapeutic applications.
Latest Patents
Tabor's latest patents include innovative compositions and methods for producing a composition that provides mammalian cells capable of producing recombinant CTLA4-Ig and its variants. This invention not only outlines the production of CTLA4-Ig but also details the formulations and methods for mass-producing and purifying this important recombinant protein. His work on the carbohydrate content of CTLA4 molecules further emphasizes the versatility and importance of his research in the field.
Career Highlights
Throughout his career, Tabor has been associated with Bristol-Myers Squibb Company, where he has contributed to various projects aimed at advancing biopharmaceuticals. His expertise in recombinant protein production has positioned him as a key figure in the industry.
Collaborations
Tabor has collaborated with several esteemed colleagues, including Kirk J Leister and Eugene J Schaefer. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
John Malcolm Tabor's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the development of therapeutic proteins, showcasing the importance of innovation in medical science.